Literature DB >> 21920027

Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance.

Yu Chen, Daigo Inoyama, Ah-Ng Tony Kong, Lesa J Beamer, Longqin Hu.   

Abstract

The Keap1-Nrf2 interaction plays important roles in regulation of Nrf2 activity and induction of chemopreventive enzymes. To better understand the interaction and to determine the minimal Nrf2 sequence required for Keap1 binding, we synthesized a series of Nrf2 peptides containing ETGE motif and determined their binding affinities to the Kelch domain of Keap1 in solution using a surface plasmon resonance-based competition assay. The equilibrium dissociation constant for the interaction between 16mer Nrf2 peptide and Keap1 Kelch domain in solution (K(solution)(D)) was found to be 23.9 nM, which is 10× lower than the surface binding constant (K(surface)(D)) of 252 nM obtained for the direct binding of Keap1 Kelch domain to the immobilized 16mer Nrf2 peptide on a surface plasmon resonance sensor chip surface. The binding affinity of Nrf2 peptides to Keap1 Kelch domain was not lost until after deletion of eight residues from the N-terminus of the 16mer Nrf2 peptide. The 9mer Nrf2 peptide has a moderate binding affinity with a (K(solution)(D)) of 352 nM and the affinity was increased 15× upon removal of the positive charge at the peptide N-terminus by acetylation. These results suggest that the minimal Nrf2 peptide sequence required for Keap1 binding is the 9mer sequence of LDEETGEFL.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920027      PMCID: PMC3218206          DOI: 10.1111/j.1747-0285.2011.01240.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  43 in total

Review 1.  Chemoprotection against cancer by induction of phase 2 enzymes.

Authors:  P Talalay
Journal:  Biofactors       Date:  2000       Impact factor: 6.113

2.  The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm.

Authors:  Laurie M Zipper; R Timothy Mulcahy
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

Review 3.  Characterization of protein-protein interactions by isothermal titration calorimetry.

Authors:  Adrian Velazquez-Campoy; Stephanie A Leavitt; Ernesto Freire
Journal:  Methods Mol Biol       Date:  2004

Review 4.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

5.  Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription.

Authors:  Y Katoh; K Itoh; E Yoshida; M Miyagishi; A Fukamizu; M Yamamoto
Journal:  Genes Cells       Date:  2001-10       Impact factor: 1.891

Review 6.  Gene regulation of heme oxygenase-1 as a therapeutic target.

Authors:  S Immenschuh; G Ramadori
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

Review 7.  Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors.

Authors:  Hozumi Motohashi; Tania O'Connor; Fumiki Katsuoka; James Douglas Engel; Masayuki Yamamoto
Journal:  Gene       Date:  2002-07-10       Impact factor: 3.688

8.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.

Authors:  Nobunao Wakabayashi; Ken Itoh; Junko Wakabayashi; Hozumi Motohashi; Shuhei Noda; Satoru Takahashi; Sumihisa Imakado; Tomoe Kotsuji; Fujio Otsuka; Dennis R Roop; Takanori Harada; James Douglas Engel; Masayuki Yamamoto
Journal:  Nat Genet       Date:  2003-09-28       Impact factor: 38.330

Review 9.  Regulatory mechanisms controlling gene expression mediated by the antioxidant response element.

Authors:  Truyen Nguyen; Philip J Sherratt; Cecil B Pickett
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

10.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.

Authors:  Albena T Dinkova-Kostova; W David Holtzclaw; Robert N Cole; Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Masayuki Yamamoto; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

View more
  30 in total

1.  Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).

Authors:  Mengqi Zhong; Andrew Lynch; Samantha N Muellers; Stefan Jehle; Lingqi Luo; David R Hall; Reina Iwase; James P Carolan; Megan Egbert; Amanda Wakefield; Kristina Streu; Christine M Harvey; Paula C Ortet; Dima Kozakov; Sandor Vajda; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

2.  Engineering a genetically encoded competitive inhibitor of the KEAP1-NRF2 interaction via structure-based design and phage display.

Authors:  Gurkan Guntas; Steven M Lewis; Kathleen M Mulvaney; Erica W Cloer; Ashutosh Tripathy; Thomas R Lane; Michael B Major; Brian Kuhlman
Journal:  Protein Eng Des Sel       Date:  2015-10-20       Impact factor: 1.650

Review 3.  Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.

Authors:  Duncan E Scott; Andrew R Bayly; Chris Abell; John Skidmore
Journal:  Nat Rev Drug Discov       Date:  2016-04-11       Impact factor: 84.694

4.  Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis.

Authors:  Youbo Zhang; Tingting Yan; Dongxue Sun; Cen Xie; Tianxia Wang; Xiaoyan Liu; Jing Wang; Qiong Wang; Yuhong Luo; Ping Wang; Tomoki Yagai; Kristopher W Krausz; Xiuwei Yang; Frank J Gonzalez
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

5.  Blocking of JB6 cell transformation by tanshinone IIA: epigenetic reactivation of Nrf2 antioxidative stress pathway.

Authors:  Ling Wang; Chengyue Zhang; Yue Guo; Zheng-Yuan Su; Yuqing Yang; Limin Shu; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

6.  Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction.

Authors:  Daigo Inoyama; Yu Chen; Xinyi Huang; Lesa J Beamer; Ah-Ng Tony Kong; Longqin Hu
Journal:  J Biomol Screen       Date:  2011-12-07

7.  Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.

Authors:  Jesus M Ontoria; Ilaria Biancofiore; Paola Fezzardi; Federica Ferrigno; Esther Torrente; Stefania Colarusso; Elisabetta Bianchi; Matteo Andreini; Alexandros Patsilinakos; Georg Kempf; Martin Augustin; Stefan Steinbacher; Vincenzo Summa; Robert Pacifici; Ignacio Muñoz-Sanjuan; Larry Park; Alberto Bresciani; Celia Dominguez; Leticia Toledo Sherman; Steven Harper
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

8.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

9.  Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1.

Authors:  Toshiaki Fukutomi; Kenji Takagi; Tsunehiro Mizushima; Noriaki Ohuchi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-12-23       Impact factor: 4.272

10.  Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction.

Authors:  Sumi Lee; Longqin Hu
Journal:  Med Chem Res       Date:  2020-04-10       Impact factor: 1.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.